 | Gain Therapeutics, Inc. | |||
| NasdaqGM : GANX || Location: United States | ||||
$3.98-0.02 (-0.5%) |
0.01 M | 3.965 - 4.045 | ||
| Last Updated:08/17/2022 12:32 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 29, 2022 | 0.051 M |
| July 15, 2022 | 0.039 M |
| June 30, 2022 | 0.048 M |
| June 15, 2022 | 0.070 M |
| May 31, 2022 | 0.059 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2022 | -0.31 | -0.43 | -38.70% |
| 03/31/2022 | -0.37 | -0.28 | 24.30% |
| 12/31/2021 | -0.49 | -0.32 | 34.70% |
| 09/30/2021 | -0.36 | -0.39 | -8.30% |
| 06/30/2021 | -0.30 | -0.30 | 0.00% |
GANX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 11.883M | Shares Float | 8.742M |
| Short Float | 0.051M | Market Cap | 49.31M |
| Institution ownership | 9.80% | Insider ownership | 24.340% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -1.23 | Forward EPS | -1.55 |